157 related articles for article (PubMed ID: 36038343)
1. [Clinical characteristics and prognosis analysis of 498 cases with drug-induced liver injury].
Yang X; Tu RF; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):735-740. PubMed ID: 36038343
[No Abstract] [Full Text] [Related]
2. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
[TBL] [Abstract][Full Text] [Related]
4. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
5. [A clinical analysis of 22 patients with drug-induced liver injury caused by traditional Chinese medicine Periploca forrestii Schltr].
Feng JC; Wang HY; Zhou AQ; Wang DX; Xie Q; Jiang H; Qian GM
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):692-695. PubMed ID: 27788727
[No Abstract] [Full Text] [Related]
6. Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.
Sunil Kumar N; Remalayam B; Thomas V; Ramachandran TM; Sunil Kumar K
J Clin Exp Hepatol; 2021; 11(2):163-170. PubMed ID: 33746440
[TBL] [Abstract][Full Text] [Related]
7. Differences in clinical characteristics among 726 patients with Chinese herbal medicine- or Western medicine-induced liver injury.
Tan K; Yang W; Pang L; Hou F
Medicine (Baltimore); 2022 Aug; 101(32):e29909. PubMed ID: 35960048
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
Xu HM; Chen Y; Xu J; Zhou Q
World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
Asgarshirazi M; Shariat M; Sheikh M
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):296-302. PubMed ID: 28603098
[TBL] [Abstract][Full Text] [Related]
11. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
[TBL] [Abstract][Full Text] [Related]
12. Marked Increase of Gamma-Glutamyltransferase as an Indicator of Drug-Induced Liver Injury in Patients without Conventional Diagnostic Criteria of Acute Liver Injury.
Weber S; Allgeier J; Denk G; Gerbes AL
Visc Med; 2022 Jun; 38(3):223-228. PubMed ID: 35814980
[TBL] [Abstract][Full Text] [Related]
13. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of peripheral blood Gamma-glutamyl transferase in different liver diseases.
Xing M; Gao M; Li J; Han P; Mei L; Zhao L
Medicine (Baltimore); 2022 Jan; 101(1):e28443. PubMed ID: 35029891
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features and Risk Factors for Drug-Induced Liver Injury: A Retrospective Study From China.
Ma X; Chen Z; An J; Zhang C
Clin Ther; 2024 May; ():. PubMed ID: 38821767
[TBL] [Abstract][Full Text] [Related]
16. [An analysis on clinical characteristics and prognosis-related risk factors in patients with drug-induced liver injury].
Wei Q; Li L; Zeng XQ; Abidan BHTYE; Yin J; Gao H; Guo JS
Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):214-221. PubMed ID: 38584102
[No Abstract] [Full Text] [Related]
17. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
18. Association of Cytokines with Clinical Indicators in Patients with Drug-Induced Liver Injury.
Cao WH; Jiang TT; Shen G; Deng W; Wang SY; Zhang ZY; Li XX; Lu Y; Zhang L; Liu RY; Chang M; Wu SL; Gao YJ; Hao HX; Chen XX; Hu LP; Xu MJ; Yi W; Xie Y; Li MH
Biomed Environ Sci; 2024 May; 37(5):494-502. PubMed ID: 38843922
[TBL] [Abstract][Full Text] [Related]
19. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
[No Abstract] [Full Text] [Related]
20. An analysis of the efficacy and safety of compound glycyrrhizin injections in the treatment of drug-induced liver injury using a nationwide database.
Yao L; Zhang J; Jin J; Li H; Li L; Han X; Raza HK; Li X; Mao Y
Int J Clin Pharm; 2022 Jun; 44(3):731-740. PubMed ID: 35438473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
